Who are we?
The ACTG at MGH has been conducting HIV clinical trials since 1987. Our research has contributed to advancements in the standard of care for people living with HIV including the development of combination oral therapy, long-acting injectable therapy, and managing drug resistance. Our mission is to conduct scientifically rigorous clinical research to have a positive impact on the well-being of persons infected with HIV.
For more information, visit us: ACTG Website
How do I get involved?
Scroll down to view the summaries of our active studies below and ask about enrolling!
To talk to a member of the study team about any of our clinical trials, please email findacure@partners.org or call 617-726-3819!
Actively Enrolling HIV Studies
Volunteers living with HIV needed to help test triple immune strategy for HIV remission!
This study is evaluating three new treatments given in sequence to improve the response of your immune system to HIV allowing for longer periods in which the virus is controlled and in which daily HIV medication is not needed.
- Any Sex/Gender
- gender
- 18+
- age
- 64 visits
- time required
Rajesh Gandhi, MD
Massachusetts General Hospital